POSTER SESSION V
Wednesday, March 21, 2012   —  9:30 AM - 12:00 Noon
CC Exhibit Hall B3 & C


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


PANCREAS PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
247 Clinico-Pathologic and Prognostic Study of 59 Acinar Cell Carcinomas of the Pancreas (1859)
S La Rosa, VN Adsay, L Albarello, S Asioli, S Casnedi, F Franzi, A Marando, K Notohara, F Sessa, A Vanoli, L Zhang, C Capella - Ospedale di Circolo, Varese, Italy; Emory University, Atlanta, GA; San Raffaele Scientific Institute, Milan, Italy; University of Turin, Turin, Italy; Hospital De Hautepierre, Strasbourg, France; University of Insubria, Varese, Italy; Kurashiki Central Hospital, Kurashiki, Japan; University of Pavia, Pavia, Italy; Mayo Clinic, Rochester, MN 		Add
248 Expression of O6-Methylguanine DNA Methyltransferase (MGMT) in Midgut and Pancreatic Neuroendocrine Tumors, Solid Pseudopapillary Tumors and Acinar Cell Carcinomas (1870)
MD Siegelin, S Shaikh, R Fine, H Remotti - Columbia University College of Physicians & Surgeons, New York, NY 		Add
249 Combined Progesterone Receptor and PTEN Expression Predicts Metastasis and Survival in Patients with Pancreatic Neuroendocrine Tumors (1844)
JS Estrella, R Broaddus, JC Yao, H Wang, A Rashid - U.T. M.D. Anderson Cancer Center, Houston, TX 		Add
250 Comparative Analysis of Different Counting Methodologies for Ki-67 in Pancreatic Neuroendocrine Tumors (1839)
P Bagci, N Ohike, N Dursun, K-T Jang, T Tajiri, O Basturk, SY Kong, L Ducato, M Reid, V Adsay - Emory University, Atlanta; Showa University, Tokyo, Japan; MSKCC, New York 		Add
251 Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors (1867)
TN Oberg, JS Voss, CM Lohse, T-T Wu, TC Smyrk, L Zhang - Mayo Clinic, Rochester, MN 		Add
252 Comparison of Semi-Quantitative Versus Quantitative Grading System in Endocrine Tumors of the Pancreas: Which One Should Be Applied? (1875)
B Weynand, I Borbath, C Sempoux, J-F Gigot, A Jouret- Mourin - Cliniques Universitaires St Luc, Brussels, Belgium 		Add
253 Is Islet 1 (Isl1) a Sensitive and Specific Marker for Pancreatic Neuroendocrine Tumors and Their Metastases (1848)
RP Graham, B Shrestha, BL Caron, TC Smyrk, KL Grogg, RV Lloyd, L Zhang - Mayo Clinic, Rochester, MN; University of Wisconsin, Madison, WI 		Add
254 Altered ATRX/DAXX Expression and Telomere Length of Pancreatic Neuroendocrine Tumors in MEN-1 Syndrome (1843)
RF de Wilde, CM Heaphy, A Maitra, AK Meeker, BH Edil, CL Wolfgang, T Ellison, RD Schulick, IQ Molenaar, GD Valk, MR Vriens, IHM Borel Rinkes, GJA Offerhaus, RH Hruban, KE Matsukuma - Johns Hopkins Medical Institutions, Baltimore, MD; University Medical Center Utrecht, Utrecht, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands 		Add
255 Loss of PTEN Expression Is Associated with Poor Prognosis in Patients with Ampullary Adenocarcinoma (1869)
S Shroff, M Overman, A Rashid, H Wang, R Shroff, S Hamilton, MH Katz, JE Lee, HF Gomez, JL Abbruzzese, JB Fleming, H Wang - The University of Texas MD Anderson Cancer Center, Houston, TX 		Add
256 Expression of Amphiregulin, Epidermal Growth Factor Receptor (EGFR) and Phosphorylated EGFR in Ampullary Carcinoma (1864)
K Mikhitarian, N Merchant, F Revetta, C Shi - Vanderbilt University Medical Center, Nashville 		Add